Projects per year
Personal profile
Fingerprint
Dive into the research topics where Blinera Juniku is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
Targeting the splicing factor TFIP11 in cancer by an intrinsically disordered protein-based drug design strategy
Juniku, B. (PI), Michaux, C. (Supervisor) & Mottet, D. (CoI)
1/01/24 → 30/09/25
Project: Research
-
Targeting the splicing factor TFIP11 in cancer by an intrinsically disordered protein-based drug design strategy
Juniku, B. (PI), Michaux, C. (Supervisor) & Mottet, D. (CoI)
1/10/21 → 31/12/23
Project: Research
-
Intrinsic disorder and salt-dependent conformational changes of the N-terminal region of TFIP11 splicing factor
Juniku, B., Mignon, J., Carême, R., Genco, A., Obeid, A. M., Mottet, D., Monari, A. & Michaux, C., Oct 2024, In: International journal of biological macromolecules. 277, 3, 134291.Research output: Contribution to journal › Article › peer-review
Open Access -
Author Correction: Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection
Petitjean, S. J. L., Chen, W., Koehler, M., Jimmidi, R., Yang, J., Mohammed, D., Juniku, B., Stanifer, M. L., Boulant, S., Vincent, S. P. & Alsteens, D., Dec 2022, In: Nature Communications. 13, 1, 3611.Research output: Contribution to journal › Comment/debate › peer-review
Open AccessFile33 Downloads (Pure) -
Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection
Petitjean, S. J. L., Chen, W., Koehler, M., Jimmidi, R., Yang, J., Mohammed, D., Juniku, B., Stanifer, M. L., Boulant, S., Vincent, S. & Alsteens, D., Dec 2022, In: Nature Communications. 13, 1, 2564.Research output: Contribution to journal › Article › peer-review
Open AccessFile74 Downloads (Pure)